logo
  

Coca-Cola Lifts FY22 Forecast - Update

While reporting higher financial results for the third quarter on Tuesday, beverages giant Coca-Cola Co. (KO) raised its fiscal 2022 outlook for comparable earnings growth and organic revenue growth.

In pre-market activity on the NYSE, Coca-Cola shares were gaining around 2.8 percent to trade at $59.20.

For fiscal 2022, the company now expects to deliver comparable comparable earnings per share growth of 6 percent to 7 percent from last year's $2.32 per share, with a 9 percent currency headwind. Comparable currency neutral earnings per share growth of 15 percent to 16 percent.

Previously, the company expected comparable earnings to grow in a range of 5 to 6 percent from last year, with a 9 percent currency headwind.

Further, the company now expects to deliver organic revenue growth of 14 percent to 15 percent, with a 7 percent currency headwind and 2 percent tailwind from acquisitions and divestitures. The earlier projected organic revenue growth was 12 to 13 percent, with a 6 percent currency headwind and 2 percent tailwind from acquisitions and divestitures.

For the fourth quarter, comparable net revenues are expected to include an 8 percent currency headwind, and comparable earnings per share is expected to include 9 percent currency headwind.

For fiscal 2023, comparable net revenues are expected to include an approximate 5 percent to 6 percent currency headwind, and comparable earnings per share is expected to include an approximate 7 percent to 8 percent currency headwind.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT